Life and death by death receptors

被引:496
作者
Guicciardi, Maria Eugenia [1 ]
Gores, Gregory J. [1 ]
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Fas/CD95/APO1; TNF; TRAIL; Bcl-2; family; caspases; MAP kinases; NF-KAPPA-B; APOPTOSIS-INDUCING LIGAND; TRAIL-INDUCED APOPTOSIS; NECROSIS-FACTOR RECEPTOR; FAS-MEDIATED APOPTOSIS; DOMAIN KINASE RIP; CELL-DEATH; TNF-RECEPTOR; LIVER-REGENERATION; CASPASE ACTIVATION;
D O I
10.1096/fj.08-111005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Death receptors are members of the tumor necrosis factor receptor superfamily characterized by a cytoplasmic region known as the "death domain" that enables the receptors to initiate cytotoxic signals when engaged by cognate ligands. Binding to the ligand results in receptor aggregation and recruitment of adaptor proteins, which, in turn, initiates a proteolytic cascade by recruiting and activating initiator caspases 8 and 10. Death receptors were once thought to primarily induce cytotoxic signaling cascades. However, recent data indicate that they initiate multiple signaling pathways, unveiling a number of nonapoptosis-related functions, including regulation of cell proliferation and differentiation, chemokine production, inflammatory responses, and tumor-promoting activities. These noncytotoxic cascades are not simply a manifestation of inhibiting proapoptotic pathways but are intrinsically regulated by adaptor protein and receptor internalization processes. Insights into these various death receptor signaling pathways provide new therapeutic strategies targeting these receptors in pathophysiological processes.-Guicciardi, M. E., Gores, G. J. Life and death by death receptors. FASEB J. 23, 1625-1637 (2009)
引用
收藏
页码:1625 / 1637
页数:13
相关论文
共 143 条
  • [1] Molecular ordering of the initial signaling events of CD95
    Algeciras-Schimnich, A
    Shen, L
    Barnhart, BC
    Murmann, AE
    Burkhardt, JK
    Peter, ME
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) : 207 - 220
  • [2] Actin dependent CD95 internalization is specific for Type I cells
    Algeciras-Schimnich, A
    Peter, ME
    [J]. FEBS LETTERS, 2003, 546 (2-3) : 185 - 188
  • [3] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [4] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [5] To kill a tumor cell: the potential of proapoptotic receptor agonists
    Ashkenazi, Avi
    Herbst, Roy S.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06) : 1979 - 1990
  • [6] CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells
    Barnhart, BC
    Legembre, P
    Pietras, E
    Bubici, C
    Franzoso, G
    Peter, ME
    [J]. EMBO JOURNAL, 2004, 23 (15) : 3175 - 3185
  • [7] The CD95 type I/type II model
    Barnhart, BC
    Alappat, EC
    Peter, ME
    [J]. SEMINARS IN IMMUNOLOGY, 2003, 15 (03) : 185 - 193
  • [8] cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
    Bertrand, Mathieu J. M.
    Milutinovic, Snezana
    Dickson, Kathleen M.
    Ho, Wai Chi
    Boudreault, Alain
    Durkin, Jon
    Gillard, John W.
    Jaquith, James B.
    Morris, Stephen J.
    Barker, Philip A.
    [J]. MOLECULAR CELL, 2008, 30 (06) : 689 - 700
  • [9] Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL
    Bodmer, JL
    Meier, P
    Tschopp, J
    Schneider, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) : 20632 - 20637
  • [10] SELF-ASSOCIATION OF THE DEATH DOMAINS OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR AND FAS/APO1 PROMPTS SIGNALING FOR TNF AND FAS/APO1 EFFECTS
    BOLDIN, MP
    METT, IL
    VARFOLOMEEV, EE
    CHUMAKOV, I
    SHEMERAVNI, Y
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) : 387 - 391